Top-News
Pharmazeutika Frankreich

Sartorius Stedim Biotech News

Aktie
WKN:  A2AJKS ISIN:  FR0013154002 US-Symbol:  SDMHF
179,25 €
-4,50 €
-2,45%
19:06:29 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
92,16 Mio.
Marktkapitalisierung *
16,93 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 24.06.2023

Unternehmensmeldungen

18.04.24 - DGAP
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
Sartorius Stedim Biotech SA / Key word(s): Quarter Results Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 18-Apr-2024 / 07:02 CET/CEST Aubagne, ...
26.03.24 - DGAP
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech SA / Key word(s): AGM/EGM Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. 26-March-2024 / 16:18 CET/CEST Aubagne, ...
16.02.24 - DGAP
Sartorius Stedim Biotech releases Universal Registration Document 2023
Sartorius Stedim Biotech SA / Key word(s): Annual Results Sartorius Stedim Biotech releases Universal Registration Document 2023 16-Feb-2024 / 10:00 CET/CEST Aubagne, ...
07.02.24 - DGAP
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Sartorius Stedim Biotech SA / Key word(s): Dividend/AGM/EGM Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual ...
07.02.24 - DGAP
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ ...
06.02.24 - DGAP
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Sartorius Stedim Biotech SA Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription ...
26.01.24 - DGAP
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook
Sartorius Stedim Biotech SA / Key word(s): Annual Results/Preliminary Results Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 ...
19.10.23 - DGAP
Sartorius Stedim Biotech SA: Nine-month results 2023 of Sartorius Stedim Biotech
Sartorius Stedim Biotech SA / Key word(s): 9 Month figures/Quarter Results Sartorius Stedim Biotech SA: Nine-​month results 2023 of Sartorius Stedim Biotech 19-Oct-2023 / 07:00 ...
12.10.23 - DGAP
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-​announces preliminary 9-month results and lowers forecast for 2023 12-Oct-2023 / 21:05 ...
21.07.23 - DGAP
Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
Sartorius Stedim Biotech SA / Key word(s): Half Year Results Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech 21-Jul-2023 / 07:00 CET/CEST ...
18.07.23 - DGAP
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus
Sartorius Stedim Biotech SA / Key word(s): Mergers & Acquisitions/Acquisition Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus 18-Jul-2023 ...
16.06.23 - DGAP
Sartorius Stedim Biotech lowers forecast for 2023
Sartorius Stedim Biotech SA / Key word(s): Change in Forecast Sartorius Stedim Biotech lowers forecast for 2023 16-Jun-2023 / 22:30 CET/CEST Sartorius Stedim Biotech lowers ...
20.04.23 - DGAP
Sartorius Stedim Biotech SA: First-quarter results 2023 of Sartorius Stedim Biotech
Sartorius Stedim Biotech SA / Key word(s): Quarter Results Sartorius Stedim Biotech SA: First-​quarter results 2023 of Sartorius Stedim Biotech 20-Apr-2023 / 07:00 CET/CEST ...
31.03.23 - DGAP
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
Sartorius Stedim Biotech SA / Key word(s): Acquisition Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus 31-March-2023 / 08:50 CET/CEST Aubagne, March ...
27.03.23 - DGAP
Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board
Sartorius Stedim Biotech SA / Key word(s): Personnel/AGM/EGM Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; ...
08.02.23 - DGAP
Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting
Sartorius Stedim Biotech SA / Key word(s): Dividend Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per ...

Newssuche

Videos

29.05.24 +17,26%
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »